IFI16 and prostate carcinoma: Within prostate cancer, the silencing of CD1A-IFI16 genes is also noteworthy in that it points to tumor cell-intrinsic factors contributing to the escape from immune surveillance, in addition to the proposed immunosuppressive effects of the tumor microenvironment.